Frontiers in Pharmacology,
Journal Year:
2024,
Volume and Issue:
15
Published: Aug. 27, 2024
Background
Few
studies
have
previously
evaluated
the
long-term
impact
of
initiating
combined
use
alcohol
and
cocaine
early-in-life
during
adolescence.
Our
preclinical
study
characterized
changes
in
affective-like
behavior
and/or
voluntary
ethanol
consumption
emerging
later
on
adulthood
induced
by
a
prior
adolescent
drug
exposure,
as
well
tested
therapeutical
interventions
(i.e.,
cannabidiol
or
ketamine)
to
prevent
observed
effects.
Methods
We
performed
three
independent
with
male
female
Sprague-Dawley
rats,
treated
adolescence
(postnatal
days,
PND
29–38)
non-contingent
paradigms
ethanol,
cocaine,
their
combination
vehicle.
Later
on,
adult
rats
were
(1)
scored
for
state
(forced-swim,
elevated-plus
maze,
novelty-suppressed
feeding,
sucrose
preference),
(2)
allowed
freely
drink
6
weeks
(two-bottle
choice),
(3)
ketamine
before
given
access
adulthood.
Results
No
signs
increased
negative
affect
following
treatments.
However,
exposure
was
risk-factor
developing
an
adulthood,
both
rats.
This
risk
similar
when
since
alone
showed
no
effects
intake.
Finally,
exposed
pretreated
(and/or
ketamine,
but
just
females)
reduced
consumption.
Conclusion
data
provided
two
options
capable
preventing
early
initiation
decreasing
Frontiers in Psychiatry,
Journal Year:
2023,
Volume and Issue:
14
Published: March 24, 2023
Alcohol
Use
Disorder
(AUD)
ranks
among
the
most
prevalent
mental
disorders,
extracting
~$250
billion/year
in
US
alone
and
producing
myriad
medical
social
harms.
Also,
number
of
deaths
related
to
problem
drinking
has
been
increasing
dramatically.
Compulsive
alcohol
drinking,
characterized
by
intake
that
persists
despite
negative
consequences,
can
be
particularly
important
a
major
obstacle
treatment.
With
people
suffering
from
AUD
during
past
years,
there
is
critical
need
understand
neurobiology
compulsive
drives
for
alcohol,
as
well
development
novel
pharmacological
therapies.
Here
we
discuss
rodent
compulsion-like
(CLAD)
models,
focusing
on
two
widely
used
adverse
stimuli
model
responding,
quinine
adulteration
footshook-resistant
intake.
For
both
cases,
goal
uncover
behavior
patterns
brain
circuits
underlie
drive
even
face
consequences.
We
caveats,
benefits,
potential
mechanisms,
models
consequence-resistant
responding
more
generally,
especially
highlight
some
advantages
quinine-resistance
over
footshook-resistance.
Further,
since
this
review
contributes
Special
issue
focused
Molecular
Aspects
Drug
Use,
our
new
findings
showing
how
noradrenergic
system
CLAD
responding.
In
particular,
comment
importance
α1
β
adrenergic
receptors
(ARs)
targets
treating
AUD.
Biology of Sex Differences,
Journal Year:
2023,
Volume and Issue:
14(1)
Published: Nov. 13, 2023
Binge
alcohol
drinking
is
a
risk
factor
linked
to
numerous
disease
states
including
use
disorder
(AUD).
While
men
binge
drink
more
than
women,
this
demographic
gap
quickly
shrinking,
and
preclinical
studies
demonstrate
that
females
consistently
consume
males.
Further,
women
are
at
increased
for
the
co-expression
of
AUD
with
neuropsychiatric
diseases
such
as
anxiety
mood
disorders.
However,
little
understood
about
chronic
voluntary
its
long-term
effects
on
behavior.
Here,
we
sought
characterize
sex
differences
in
protracted
abstinence
anxiety-
affective-related
behaviors
males
females.
British Journal of Pharmacology,
Journal Year:
2023,
Volume and Issue:
180(18), P. 2377 - 2392
Published: April 13, 2023
Abstract
Background
and
Purpose
Chronic
pain
is
considered
a
key
factor
contributing
to
alcohol
use
disorder
(AUD).
The
mechanisms
responsible
for
chronic
associated
with
consumption
are
unknown.
We
evaluated
the
development
of
in
mouse
model
dependence
investigate
role
neuroinflammation.
Experimental
Approach
chronic‐intermittent
ethanol
two‐bottle
choice
CIE‐2BC
paradigm
generates
three
groups:
alcohol‐dependent
escalating
intake,
nondependent
(moderate
drinking)
alcohol‐naïve
control
male
female
mice.
measured
mechanical
allodynia
during
withdrawal
after
last
voluntary
drinking.
Immunoblotting
was
used
evaluate
protein
levels
IBA‐1,
CSFR,
IL‐6,
p38
ERK2/1
spinal
cord
tissue
dependent
non‐dependent
animals.
Key
Results
found
significant
escalation
drinking
group
compared
group.
developed
72
h
withdrawal,
which
completely
reversed
observed
an
increased
hypersensitivity
naïve
50%
Increased
IBA‐1
CSFR
expression
both
hypersensitivity‐abstinence
related
neuropathy‐alcohol
mice,
IL‐6
ERK1/2
activation
mice
hypersensitivity‐related
abstinence,
but
not
alcohol‐evoked
neuropathic
pain.
Conclusions
Implications
induces
two
distinct
conditions
specific
type
exposure:
abstinence‐related
about
half
Neurobiology of Stress,
Journal Year:
2024,
Volume and Issue:
30, P. 100618 - 100618
Published: Feb. 20, 2024
Alcohol
Use
Disorder
(AUD)
is
a
leading
cause
of
death
and
disability
worldwide,
but
current
treatments
are
insufficient
in
fully
addressing
the
symptoms
that
often
lead
to
relapses
alcohol
consumption.
The
brain's
serotonin
system
has
been
implicated
AUD
for
decades
major
regulator
stress-related
behaviors
associated
with
increased
This
review
will
discuss
literature
on
association
between
neurobiological
adaptations
systems
humans
as
well
effectiveness
receptor
manipulations
alcohol-related
like
consumption
withdrawal.
We
further
how
these
findings
relate
animal
models,
including
comparison
systemic
pharmacological
modulating
next
provide
detailed
overview
brain
region-specific
roles
signaling
preclinical
highlighting
complexity
forming
cohesive
model
function
providing
possible
avenues
more
effective
therapeutic
intervention.
Throughout
review,
we
what
known
about
sex
differences
sequelae
role
sequelae.
stress
critical
need
additional
studies
women
female
animals
so
may
build
clearer
path
elucidating
sex-specific
serotonergic
mechanisms
develop
better
treatments.
Alcohol Clinical and Experimental Research,
Journal Year:
2025,
Volume and Issue:
unknown
Published: March 9, 2025
Alcohol
use
disorder
(AUD)
and
major
depressive
(MDD)
are
often
comorbid,
it
is
estimated
that
between
15
%
to
33%
of
people
dependent
on
alcohol
have
an
MDD
diagnosis.
Mood-related
symptoms
also
common
in
humans
during
acute
withdrawal,
but
by
most
accounts,
abate
after
2-4
weeks
abstinence.
Preclinical
studies,
important
for
understanding
the
etiology
finding
treatments
this
comorbidity,
find
depression-like
anxiety-like
phenotypes
early
abstinence
along
with
protracted
negative
affect
detectable
past
2
postcessation.
In
narrative
review,
we
focus
translational
divergence
AUD
comorbidity
a
time
line
mismatch
species
concurrent
+
following
AUD.
We
highlight
preclinical
success
clinical
failure
classic
antidepressants
relative
absence
withdrawal
high-drinking
selected
lines
mice
rats.
suggest
sources
these
discrepancies,
including
discussion
relief/reward-driven
drinking
subpopulations
future
directions
field.